OssiMend BA in Posterolateral Instrumented Lumbar Fusion

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 21, 2021

Primary Completion Date

December 30, 2026

Study Completion Date

January 30, 2027

Conditions
Spinal DiseaseDegenerative Disc Disease
Interventions
DEVICE

OssiMend™ Bioactive Moldable

Lumbar Spine fusion with OssiMend™ Bioactive Moldable

Trial Locations (4)

92024

NOT_YET_RECRUITING

San Diego Neurosurgery, Encinitas

97401

COMPLETED

McKenzie-willamette Medical Center, Eugene

06102

RECRUITING

Hartford Hospital, Hartford

08873

NOT_YET_RECRUITING

University Orthopaedic Associates, Division of OrthoNJ, Somerset

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Collagen Matrix

INDUSTRY

NCT04775537 - OssiMend BA in Posterolateral Instrumented Lumbar Fusion | Biotech Hunter | Biotech Hunter